Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin:: A synergistic drug combination

被引：42

作者：

Matsumura, S ^{[1
]}

Simor, AE ^{[1
]}

机构：

[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Microbiol, SD Lab Serv, N York, ON M4N 3M5, Canada

来源：

CLINICAL INFECTIOUS DISEASES | 1998年 / 27卷 / 06期

关键词：

D O I：

10.1086/517755

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：1554 / 1556

页数：3

相关论文

共 7 条

[1] INVITRO ACTIVITY OF RP 59500, A NEW SEMISYNTHETIC STREPTOGRAMIN ANTIBIOTIC, AGAINST GRAM-POSITIVE BACTERIA
BRUMFITT, W
HAMILTONMILLER, JMT
SHAH, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 : 29 - 37
[2] DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR
DUTKAMALEN, S
EVERS, S
COURVALIN, P
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) : 24 - 27
[3] Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to Enterococci with VanA/VanB resistance patterns
Furlong, WB
Rakowski, TA
[J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) : 163 - 164
[4] Quinupristin-dalfopristin (RP 59500): An injectable streptogramin combination
Griswold, MW
Lomaestro, BM
Briceland, LL
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (17) : 2045 - 2053
[5] Moellering RC, 1998, CLIN INFECT DIS, V26, P1196, DOI 10.1086/520283
[6] National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[7] Vijayvargiya R, 1996, J AM SOC NEPHROL, V7, P536